Showing results (151-160 of 250) with videos related to

Sort By:
Pageof 25
Nature Genetics|August 8, 2017
TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancerKen J Kron, Alexander Murison, Stanley Zhou, et al.
British Journal of Cancer|July 17, 2015
BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenograftsI Lohse, A Borgida, P Cao, et al.
BMC Urology|July 2, 2021
Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancerBecky A S Bibby, Niluja Thiruthaneeswaran, Lingjian Yang, et al.
Cancer Research|October 23, 2013
miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1Xiaoyong Huang, Samira Taeb, Sahar Jahangiri, et al.
International Journal of Radiation Oncology, Biology, Physics|June 2, 1998
T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local controlP Warde, B O'Sullivan, R G Bristow, et al.
Cancer Research|October 13, 2021
Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate TumorsJames R Hawley, Stanley Zhou, Christopher Arlidge, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
Clinical Genitourinary Cancer|January 29, 2019
Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder CancerDi Maria Jiang, Haiyan Jiang, Peter W M Chung, et al.
The Prostate|April 8, 2009
High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancerAdrian S Ishkanian, Chad A Mallof, James Ho, et al.
Pageof 25